We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsLeafly PicksCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Leafly Picks
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
  • Help
  1. Home
  2. News
  3. Industry
  4. Americans will spend $60 billion on illicit marijuana this year, report says
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Industry

Americans will spend $60 billion on illicit marijuana this year, report says

Bruce BarcottLast updated September 16, 2020
illegal-marijuana-sales-United-States
An estimated 72% of all U.S. marijuana sales happen on the illicit market, due to cannabis prohibition enforced by 39 states. (AdobeStock)

Studies estimate that between 12% to 14% of adult Americans enjoy cannabis. That’s a massive group of consumers—and they spend billions of dollars every year on marijuana. Unfortunately, according to a new report, more than 71% of that spending goes to the illicit market, due to various forms of cannabis prohibition enforced in 39 states.

A new report by the website GrowCola, using data from New Frontier Data’s U.S. Cannabis Report, notes that the American illicit market encompasses roughly $60 billion in annual sales. That compares to around $23 billion in legal medical and adult-use cannabis sales. (State-legal cannabis sales figures are often disputed, as there is no government tally of the federally-prohibited products. Leafly’s 2020 jobs report estimated the size of the legal American cannabis market at around $14 billion.)

Legal v.s. illicit 
cannabis sales 2020 in the U.S.

View full data here

Source: GrowCola via New Frontier Data. Note: Washington D.C. is counted as a state in the above graphic.

That’s a lot of illicit weed, Texas

Texas leads all non-legal states in its purchases. The report estimates that the Lone Star State accounts for 7% of all illicit cannabis sales in the United States. That’s roughly $4.2 billion, or more than three times the size of Colorado’s legal market.

Next on the list: North Carolina, Georgia, Virginia, and Indiana, which each account for roughly 3% of the nation’s illicit sales.

states-illegal-marijuana-sales-rank
Everything’s bigger in Texas, including the state’s appetite for cannabis. (Source: GrowCola/New Frontier Data)

600,000 jobs and $6 billion in tax revenue foregone

If the illicit market is about 2.5 times the state-legal market, as the GrowCola/New Frontier data suggests, America is missing out on hundreds of thousands of legal jobs and billions of dollars in tax revenue.

Today’s $14 to $23 billion legal cannabis market supports 243,700 full-time American jobs. Doing the math, a fully captured illicit market would add more than 600,000 full-time jobs to the national economy.

At a relatively conservative 10% tax rate, capturing $60 billion in sales would yield $6 billion in cannabis tax revenue every single year. That’s as much as New Hampshire’s entire annual state budget.

Related articles

Legal cannabis now supports 243,700 American jobs image
Image Not Found
Industry
Legal cannabis now supports 243,700 American jobs
Bruce Barcott, David Downs, and Ian Chant
February 7, 2020

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
cannabis jobsillicit marketmarijuana sales
Bruce Barcott
Bruce Barcott
Leafly Senior Editor Bruce Barcott oversees news, investigations, and feature projects. He is a Guggenheim Fellow and author of Weed the People: The Future of Legal Marijuana in America.
View Bruce Barcott's articles

The latest in Industry

  • Hemp access isn’t done yet: What you need to know about the federal government’s impending ban image
    Hemp access isn’t done yet: What you need to know about the federal government’s impending ban
    Morgan Rosendale
  • URB’N Dispensary: From pharmacist to cannabist image
    URB’N Dispensary: From pharmacist to cannabist
    Leafly Staff
  • Happy Eddie: From reality TV to real-life cannabis reform image
    Happy Eddie: From reality TV to real-life cannabis reform
    Leafly Staff
  • Delaware is open for business: Here’s where to buy legal weed image
    Delaware is open for business: Here’s where to buy legal weed
    Leafly Staff
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.